Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 8,319,411 7.601% | 3,016,557 (+56.89%) | Filing History |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | Perspective Therapeutics, Inc. CATX | FMR LLC | 5,504,822 8.164% | 5,504,822 (New Position) | Filing History |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | SITE Centers Corp. SITC | FMR LLC | 7,746,455 14.785% | 7,746,455 (New Position) | Filing History |
| 2024-10-09 11:12 am Sale | 2024-10-07 | 13D | Fidelity Multi-Strategy Credit Fund | FMR LLC | 174 70.174% | -271 (-60.90%) | Filing |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | JPMorgan International Research Enhanced Equity ETF JIRE | FMR LLC | 12,172,033 11.918% | 4,815,360 (+65.46%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Oruka Therapeutics, Inc. ORKA | FMR LLC | 5,512,300 15.345% | 5,512,300 (New Position) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 1,724,014 2.762% | -3,960,601 (-69.67%) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Sitio Royalties Corp. STR | FMR LLC | 7,445,690 9.244% | -4,789,686 (-39.15%) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | DiamondRock Hospitality Company DRH | FMR LLC | 12,284 0.005% | -14,882,683 (-99.92%) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | FMR LLC | 5,075,837 7.138% | -5,261,134 (-50.90%) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Lululemon Athletica Inc. LULU | FMR LLC | 10,687,865 9.083% | -7,473,895 (-41.15%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Belden Inc. BDC | FMR LLC | 4,486,337 10.994% | 3,539,861 (+374.00%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | BrightSpring Health Services, Inc. Common Stock BTSG | FMR LLC | 18,498,153 10.768% | 18,498,153 (New Position) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Vasta Platform Limited VSTA | FMR LLC | 0 0.000% | -1,725,714 (Position Closed) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | TransMedics Group, Inc. TMDX | FMR LLC | 2,208,308 6.604% | -2,700,920 (-55.02%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | GMS Inc. GMS | FMR LLC | 4,232,170 10.772% | 2,954,704 (+231.29%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Insulet Corporation PODD | FMR LLC | 8,068,635 11.482% | 2,165,186 (+36.68%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Terreno Realty Corporation TRNO | FMR LLC | 10,563,453 10.901% | 4,347,677 (+69.95%) | Filing History |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Exact Sciences Corporation EXAS | FMR LLC | 22,042,464 11.897% | 19,419,703 (+740.43%) | Filing History |
| 2024-09-18 11:57 am Purchase | 2024-09-18 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR LLC | 2,495,333 5.095% | 2,495,333 (New Position) | Filing History |